Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

AFFIDEA CONTINUES ITS STRATEGIC GROWTH JOURNEY, WITH ACQUISITIONS IN SPAIN, PORTUGAL AND ROMANIA

This image opens in the lightbox

News provided by

Affidea BV

04 Jul, 2022, 12:17 GMT

Share this article

Share toX

Share this article

Share toX

  • Affidea reaches 327 centres at European level, seeing up to almost 12 million patients per year
  • The Affidea Group announces today the acquisition of Clínica Nuno Álvares and Clínica de Santa Mafalda in Portugal, two Phoenix medical centres in Deva and Alba Iulia, Romania and 3 centres in Spain - the polyclinics Infanta Mercedes Medical Centre, El Mirador Polyclinic and Colmenar Viejo Radiodiagnosis
  • Since 2018 the Company has grown its revenues by a CAGR of 16% and completed 30 acquisitions with 110 new centres added to its network.

THE HAGUE, Netherlands, July 4, 2022 /PRNewswire/ -- Affidea Group announces today strategic acquisitions in three countries – Spain, Portugal and Romania — adding 7 new centres to its network and reaching 327 centres at European level, as part of its growth strategy.

In Portugal, Affidea announces the acquisition of Clínica Nuno Álvares and Clínica de Santa Mafalda, two important providers of advanced diagnostics and outpatient services in the municipality of Almada, greater Lisbon area. Clínica Nuno Alvares, located in the centre of Almada, has been an important healthcare provider in the city for over 30 years, offering a wide spectrum of medical consultations, clinical analyses and diagnostics exams. Likewise, Santa Mafalda Clinic, located in the centre of Costa Caparica, has for over 30 years provided a wide range of consultations in more than 25 clinical specialties and blood analysis. With this acquisition, Affidea Portugal reaches 19 clinics at country level, 3 laboratories and more than 300 blood collection points.

In Spain, the acquisition of the polyclinics Infanta Mercedes Medical Centre, El Mirador Polyclinic and Colmenar Viejo Radiodiagnosis brings to Affidea patients, in addition to Diagnostic Imaging, a wide range of over 25 specialty consultations. The centres collaborate with more than 30 medical societies, several clinical analysis laboratories, and serve both publicly and privately funded patients. The Infanta Mercedes Medical Centre is located in one of the busiest business and residential areas of Madrid, operating in the market since 1990, while the other two centres, El Mirador Polyclinic and Colmenar Viejo Radiodiagnosis, are located in the north of Madrid and have been operating since 2011. With this acquisition, Affidea Spain reaches 40 clinics at country level.

In Romania, with the acquisition of 2 Phoenix medical centres in Deva and Alba Iulia, the Affidea Romania network will increase to 38 centres. The two clinics provide medical imaging services (MRI, CT, Dexa), as well as consultations in various medical specialties. 

With these additions, the Affidea network reaches 327 centres at European level, working with over 11,000 professionals and seeing almost 12 million patients every year. 

Giuseppe Recchi, CEO Affidea Group, commented: "I am very proud of how successful we have been in pursuing our mission to be the diagnostic imaging service provider of choice for our patients, doctors and payors. We have reached a unique position as the leading pan-European diagnostic imaging provider, having expanded our scale, and being in the top 3 providers in every country where we operate. We select clinics that can complement our portfolio with their strong local reputation, medical offering and clinical specialities, which extend and strengthen our scope. Demand for quality health services is growing visibly stronger, and at Affidea, we are committed to meeting this demand, keeping at core what differentiates us – clinical excellence, state-of-the-art technology and an amazing network of over 11,000 professionals, of which 7,500 are clinical staff."

In June this year, Affidea was awarded the Diagnostic Provider of the Year Award at the HealthInvestor Awards 2022.

In the past 5 years, Affidea has added almost 110 centres to its network, almost doubling the size of the Group. In 2022 alone, the company has expanded in 6 countries of its operations, starting in Italy with the acquisition of Promea, a reputable outpatient provider in Piedmont, followed by an outpatient clinic in Lithuania, the Brust Zentrum Zurich centre in Switzerland, Tecma Clinic, a renowned outpatient medical provider in Valencia, Spain and the three most recent ones in Portugal, Spain and Romania.

About Affidea Group

Affidea Group (www.affidea.com) is Europe's largest provider of advanced imaging, outpatient and cancer treatment services. Founded in 1991, the company has 327 medical centres in 15 countries, advanced diagnostics, outpatient and cancer care services for more than 11 million patients annually. Due to its high standards in patient safety, Affidea is the most awarded provider of medical imaging services in Europe. More than half of the award-winning centres with 5-stars on the Eurosafe Wall of Stars, accredited by the European Society of Radiology in Europe, are Affidea centres.

Logo - https://mma.prnewswire.com/media/942742/Affidea_Group_Logo.jpg

Modal title

Also from this source

Affidea Group partners with Reset Health to launch clinically-led digital weight loss and diabetes management solution across its network

Affidea Group partners with Reset Health to launch clinically-led digital weight loss and diabetes management solution across its network

Affidea, the leading pan-European provider of community-based polyclinics, advanced diagnostics and specialist services, is excited to announce a...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

Banking & Financial Services

Banking & Financial Services

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.